Safety in numbers: risankizumab for moderate-to-severe psoriasis.
作者信息
Mirali S, Fabusiwa K, Linos E
机构信息
University of Toronto Faculty of Medicine, Toronto, ON, Canada.
Guy's and St Thomas' Hospital, London, UK.
出版信息
Br J Dermatol. 2022 Mar;186(3):394-395. doi: 10.1111/bjd.20947. Epub 2022 Feb 20.
PMID:35187640
Abstract
摘要
Zotero 插件